What's new

Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Authorised

Apr 3, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Riccardo Cotarella receives honour from Meloni

Next Article

Scientific and technical recommendations: Veterinary Medicines Regulation

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),Mometasone (furoate),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0493/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 15, 2025  0

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0

Eldisine

Eldisine

Feb 9, 2025  0